NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/23/2024
Back to search
Official data from USPTO
MEDAVAIL MEDCENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MEDAVAIL MEDCENTER
ST13
US500000085834503Class
9
Filing
85834503
Registration
4548631
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/23/2024
Trademark type
Word
Nice classes
9
Filing date
01/28/2013
Registration date
06/10/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2024
Last transaction
03/23/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/10/2013
First use in commerce
08/10/2013
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
MURRAY, DAVID T
Law office
M40
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
MedAvail, Inc.
Representatives
Bradley K. DeSandro DESANDRO LAW GROUP PLLC
Technical classification
Nice Classes
Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Computer application software for dispensers that count or measure outputsoftware for dispensers that count or measure output for use with over-the-counter and behind-the-counter drugs and pharmaceuticalseach dispenser being a remote dispensing unit as remote dispensing technology for the prescriptionover-the-counter and behind-the-counter drugs and pharmaceuticalseach remote dispensing unit being networked across networked platforms in pharmacy enterpriseseach pharmacy enterprise supplying such drugs and pharmaceuticals via its pharmaceutical supply chain to each of the networked remote dispensing unitseach of the networked remote dispensing units being controlled by the pharmacy enterprise's pharmacists and pharmacy technicians to (i) dispense such drugs and pharmaceuticals to its end user customers; and (ii) facilitate live communications between pharmacists and pharmacy technicians and their end user customers so as to disseminate information concerning patient care to its end user customers; Dispensers that count or measure output for use with over-the-counter and behind-the-counter drugs and pharmaceuticalseach dispenser being a remote dispensing unit as remote dispensing technology for the prescriptionover-the-counter and behind-the-counter drugs and pharmaceuticalseach remote dispensing unit being networked across networked platforms in pharmacy enterpriseseach pharmacy enterprise supplying such drugs and pharmaceuticals via its pharmaceutical supply chain to each of the networked remote dispensing unitseach of the networked remote dispensing units being controlled by the pharmacy enterprise's pharmacists and pharmacy technicians to (i) dispense such drugs and pharmaceuticals to its end user customers; and (ii) facilitate live communications between pharmacists and pharmacy technicians and their end user customers so as to disseminate information concerning patient care to its end user customers
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/23/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/23/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/22/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
03/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
10/18/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/10/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/19/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/19/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/17/2021
E815
TEAS SECTION 8 & 15 RECEIVED
11/10/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/10/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/03/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/02/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/29/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2014
ALIE
ASSIGNED TO LIE
04/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/28/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/01/2013
GNRT
NON-FINAL ACTION E-MAILED
11/01/2013
CNRT
SU - NON-FINAL ACTION - WRITTEN
11/01/2013
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/31/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/25/2013
IUAF
USE AMENDMENT FILED
09/30/2013
EISU
TEAS STATEMENT OF USE RECEIVED
09/30/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/13/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2013
PUBO
PUBLISHED FOR OPPOSITION
06/18/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/09/2013
DOCK
ASSIGNED TO EXAMINER
05/09/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/02/2013
NWAP
NEW APPLICATION ENTERED
01/31/2013
Continuous trademark protection
Get notified about every new filing that threatens MEDAVAIL MEDCENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.